Trinity Biotech Announces Q3 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Trinity Biotech (TRIB) Reports Q4 Loss of $0.23/sh
December 15, 2022 9:19 AM ESTTrinity Biotech (NASDAQ: TRIB) reported Q4 EPS of ($0.23), versus $0.60 reported last year. Revenue for the quarter came in at $19.5 million versus the consensus estimate of $22 million.
For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.
... More


